List of Schedule V controlled substances (U.S.)
(Redirected from List of Schedule V drugs (US))
List of Schedule V controlled substances in the United States
Overview
In the United States, controlled substances are categorized into five schedules under the Controlled Substances Act (CSA). These schedules are determined based on the substance's potential for abuse, accepted medical use, and safety or dependence liability. Schedule V substances are considered to have a lower potential for abuse relative to substances listed in Schedule IV.
Characteristics of Schedule V Substances
Schedule V controlled substances are defined by the following characteristics:
- They have a low potential for abuse relative to substances in Schedule IV.
- They have a currently accepted medical use in treatment in the United States.
- Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the substances in Schedule IV.
Common Schedule V Substances
Schedule V substances often include medications that contain limited quantities of certain narcotics. These substances are typically used for antitussive, antidiarrheal, and analgesic purposes. Some common examples include:
- Codeine preparations: These are often used in cough preparations. For example, cough syrups containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.
- Diphenoxylate preparations: When combined with atropine, diphenoxylate is used to treat diarrhea. The combination is known as Lomotil.
- Pregabalin: Although not a Schedule V substance in the U.S., pregabalin is often discussed in the context of controlled substances due to its regulation in other countries.
Legal Implications
The classification of a substance as Schedule V has specific legal implications. Prescriptions for Schedule V substances can be refilled more times than those for higher schedules, and in some states, they may be available over the counter. However, they are still subject to regulation and monitoring to prevent misuse and abuse.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD